THE European Medicines Agency (EMA) has ruled out banning or bringing in tougher restrictions on controversial painkiller Nolotil – for now. The...
Vous n'êtes pas connecté
The European Medicines Agency has rejected the Alzheimer’s drug Leqembi – a major setback for developers Eisai and Biogen. ...
THE European Medicines Agency (EMA) has ruled out banning or bringing in tougher restrictions on controversial painkiller Nolotil – for now. The...
THE European Medicines Agency (EMA) has ruled out banning or bringing in tougher restrictions on controversial painkiller Nolotil – for now. The...
Industry-Leading Research Provides 360-Degree View of Hydrogen as a Marine Fuel and Wind-Assisted Propulsion A 360-degree analysis of hydrogen as...
Industry-Leading Research Provides 360-Degree View of Hydrogen as a Marine Fuel and Wind-Assisted Propulsion A 360-degree analysis of hydrogen as...
The ASX 200 information technology sector rose ~8% in August and continues to be the top-performing sector this year, up ...
ASX health stocks down in August and trail the broader market by in 2024. AI is revolutionising healthcare, boosting diagnosis ...
Napoli and Super Eagles striker, Victor Osimhen has rejected an offer of €70m from Saudi Arabian club Al Ahli. According to Osimhen’s agent, agent...
New research from Washington University School of Medicine in St. Louis suggests that people with multiple sclerosis (MS) are far less likely to...
Antimony celebrates as the most pro-money ressie stock on the ASX during August after an out-of-the-blue export restriction of the ...
In a major blow to Iowa farmers and biofuel producers, the Environmental Protection Agency recently announced that it expects to establish biofuel...